540788 — Aspira Pathlab & Diagnostics Income Statement
0.000.00%
Last trade - 00:00- IN₹573.53m
- IN₹584.05m
- IN₹219.99m
- 66
- 22
- 41
- 38
Annual income statement for Aspira Pathlab & Diagnostics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 152 | 195 | 145 | 132 | 220 |
| Cost of Revenue | |||||
| Gross Profit | 126 | 164 | 120 | 106 | 183 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 131 | 148 | 144 | 159 | 200 |
| Operating Profit | 20.7 | 47.4 | 0.076 | -27.3 | 20.3 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 13.8 | 44.6 | -0.887 | -26.7 | 20.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 13.8 | 44.6 | -0.887 | -26.7 | 20.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 13.8 | 44.6 | -0.887 | -26.7 | 20.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 13.8 | 44.6 | -0.887 | -26.7 | 20.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.45 | 4.33 | -0.086 | -2.6 | 1.97 |